Assessment and treatment of overweight during the COVID-19 period.
*Corresponding Author:
Copyright: © 2021 . This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
Evaluation and treatment of overweight during the COVID-19 period. Adolescents were divided in groups according to the level of pericardial effusion ((group 1: 3 millimeters ; group 2: 3 millimeters - 8 millimeters and group 3: > 8 millimeters). Characteristics were presented by their mean standard deviation. Data were tested for normality by Kolmogorov-Smirnov test. As normality could be assumed for all characteristics; groups were compared by independent student-t-test (when comparing two groups :group 1 versus group 2+ 3 combined) and one- way analysis of variance (ANOVA) with least significant differences (LSD) post hoc comparison tests (when comparing 3 groups). We also analysed the influence of different characteristics on the actual measurement of pericardial effusion. The independent contribution of potential risk factors on the logarithm of pericardial effusion was then assessed by multiple linear regression analysis. Results 29 patients ( 22.2% ) were diagnosed with a pericardial effusion ( 0.35 cm-2.5 cm). After 3 months refeeding , the effusions disappeared in 18/29 patients while in 7/29 patients a pericardial effusion above 0.3 cm persisted. 4/29 patients discontinued their therapy and were lost to followup. Assessment and treatment of overweight during the COVID-19 period. Martine K.F. Docx Department of Paediatrics Queen Paola Children’s Hospital Antwerp Citation: Martine K.F. Docx , Assessment and treatment of overweight during the COVID-19 period., International Conference on Women Health Midwifery, during Oct-28-29,2021, Osaka Japan Ind Chem 2020, 6:2 Conclusion Pericardial effusions occur relatively frequently in anorexic youngsters. Risk factors: BMI 13,5 kg/m², weight loss 25% and IGF-1 100 ng/ml.. Biography : Dr. Martine Docx, Working on Department of Chronic Paediatric Diseases and Eating Disorders Chronic disease in children especially hypertension,nephrology and eating disorders Queen Paola Children’s Hospital Antwerp Belgium.
